The Malaysia pharmaceutical manufacturing market is poised for robust growth, projected to reach $4.5 billion by 2032 at a CAGR of 7.2% from 2024. Key drivers include rising demand for biologics, sterile injectables, generics, and vaccines, supported by regulatory compliance with NPRA standards and adoption of Industry...Read more
